Mitsui-7 MWCNTs are strong lung tumor promoters in B6C3F1 mice. B6C3F1 mouse lung tumors have many molecular and morphological similarities to human pulmonary tumors. In previous work, we have demonstrated that exposure to inhaled Mitsui-7 following exposure to a DNA damaging agent caused potent promotion of lung tumors. To investigate a possible threshold for Mitsui-7-induced carcinogenesis, we exposed B6C3F1 mice to a single dose of either methylcholanthrene (MC, 10 microg/g BW, i.p.) or vehicle (corn oil). One week after i.p. injections, mice were exposed by inhalation to MWCNTs (5 mg/m3, 5 hours/day, 5 days/week) or filtered air (controls) for a total of 2, 5 or 10 days. At 17 months post-exposure, mice were euthanized and examined for lung tumor formation. Thirty six percent of the filtered air controls, 33% of the MWCNT-exposed, and 47% of the MC-exposed, had a mean of 0.33, 0.33 and 0.4 tumors per mouse, respectively. By contrast, 94% of the mice which received MC followed by 10 days MWCNT had an average of 2.9 tumors per mouse while 81% of the mice exposed to 5 days of MWCNTs had 1.9 tumors per mouse, and 73% of the mice exposed to 2 days of MWCNTs had 1.2 tumors per mouse. Additionally, mice exposed to MWCNTs or MC followed by MWCNTs had larger tumor volumes than their corresponding air-exposed control groups. Preliminary data indicate a dose response in the percent of animals with tumors as well as the number of tumors per animal following exposure to MC and MWCNTs. In this study, mouse MWCNT lung burden approximates feasible human occupational exposures.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.